2004 - 2023年阿拉斯加非妊娠成人侵袭性B族链球菌病
Invasive Group B Streptococcal Disease Among Non-Pregnant Adults - Alaska, 2004-2023.
作者信息
Balta Victoria A, Bressler Sara, Massay Stephanie, Orell Laurie, Reasonover Alisa, Harker-Jones Marcella, Kretz Tony, Fischer Marc, McLaughlin Joseph, Steinberg Jonathan
机构信息
Arctic Investigations Program, Division of Infectious Disease Readiness and Innovation, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska, USA.
Epidemic Intelligence Service, Division of Workforce Development, National Center for State, Tribal, Local, and Territorial Public Health Infrastructure and Workforce, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
出版信息
J Infect Dis. 2025 Feb 27. doi: 10.1093/infdis/jiaf055.
We describe the epidemiology of invasive group B streptococcal (GBS) disease among non-pregnant Alaska adults using statewide surveillance data. During 2004-2023, 880 cases of invasive GBS disease were reported for an age-adjusted annual incidence of 9.1 (95% CI, 8.5-9.7) cases per 100,000 adults. Incidence increased 1.9-fold (95% CI, 1.6-2.2) between 2004-2013 and 2014-2023. Adults aged ≥65 years had a 4.4-fold higher risk of invasive disease compared to younger adults, and 47% of adults with invasive GBS had diabetes. Healthcare providers should be aware of populations at increased risk, potentially allowing for more prompt treatment.
我们利用全州监测数据描述了阿拉斯加非妊娠成年人侵袭性B族链球菌（GBS）疾病的流行病学情况。在2004年至2023年期间，共报告了880例侵袭性GBS疾病病例，年龄调整后的年发病率为每10万名成年人9.1例（95%置信区间，8.5 - 9.7）。2004 - 2013年至2014 - 2023年期间，发病率增加了1.9倍（95%置信区间，1.6 - 2.2）。与年轻成年人相比，65岁及以上的成年人患侵袭性疾病的风险高4.4倍，47%的侵袭性GBS成年患者患有糖尿病。医疗保健提供者应意识到风险增加的人群，这可能有助于更及时地进行治疗。
Zotero 插件